arrow_back Back to App

Genetic Data Security: Ban on Contracts with Foreign Biotechnology Companies

This Act aims to protect sensitive American genetic data by prohibiting executive agencies from contracting with specific foreign biotechnology companies deemed a national security risk. This means that the equipment and services of these companies cannot be used in federal contracts, enhancing the security of citizens' health information. The law also establishes a process for identifying and blocking other entities that might collect genetic data without informed consent.
Key points
Federal agencies are prohibited from procuring or using equipment and services from designated biotechnology companies of concern.
Four specific companies (BGI, MGI, Complete Genomics, WuXi AppTec) and their affiliates are initially named as companies of concern.
The goal is to protect US citizens' multiomic (genetic) data from access and exploitation by foreign governments and their intelligence agencies.
The prohibitions also extend to subcontractors and grant recipients who use the banned equipment in performing government contracts.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_3558
Sponsor: Sen. Peters, Gary C. [D-MI]
Process start date: 2023-12-20
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Prohibiting Foreign Access to American Genetic Information Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_3558.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-12-20.

What are the main provisions?

Key points include:

  • Federal agencies are prohibited from procuring or using equipment and services from designated biotechnology companies of concern.
  • Four specific companies (BGI, MGI, Complete Genomics, WuXi AppTec) and their affiliates are initially named as companies of concern.
  • The goal is to protect US citizens' multiomic (genetic) data from access and exploitation by foreign governments and their intelligence agencies.
  • The prohibitions also extend to subcontractors and grant recipients who use the banned equipment in performing government contracts.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Peters, Gary C. [D-MI].

What is the latest detailed status?

The latest detailed status is: Placed on Senate Legislative Calendar under General Orders. Calendar No. 521.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Security Health Economy